Refine Your Results

Click below to filter your search results

"Last Month"Undo
"Medications or Drugs"Undo
"Committee Opinion"Undo

Search Results

Return to List
Results 1–1 of 1
Title Date
1.

Aromatase Inhibitors in Gynecologic Practice

Number 663

(Replaces Committee Opinion Number 412, August 2008)

ABSTRACT Aromatase inhibitors have been used for the treatment of breast cancer ovulation induction endometriosis and other estrogenmodulated conditions For women with breast cancer bone mineral density screening is recommended with longterm aromatase inhibitor use because of risk of osteoporosis ...

June 2016

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998